Drug Search Results

Evocalcet

Alternative Names: evocalcet, khk-7580, khk7580, khk 7580
Latest Update: 2024-03-18
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: CaSR Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Japan

Approved Indications: None

Known Adverse Events: None

Company: Kyowa Hakko Kirin
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Evocalcet

Countries in Clinic: China

Active Clinical Trial Count: 1

Highest Development Phases

Phase 3: Hyperparathyroidism, Secondary|Kidney Diseases

Trial	Phase	Trial Status	Disease	Primary Completion Date	Probability of Success
CTR20190245	P3	Not yet recruiting	Hyperparathyroidism, Secondary\|Kidney Diseases	None

Recent News Events

Date	Type	Title
03/18/2024	PubMed	Calcimimetics treatment strategy for serum calcium and phosphate management in patients with secondary hyperparathyroidism undergoing dialysis: A systematic review and meta-analysis of randomized studies.
02/26/2024	PubMed	Pharmacokinetics, Pharmacodynamics, and Safety of Evocalcet (KHK7580), a Novel Calcimimetic Agent: An Open-Label, Single- and Multiple-Dose, Phase I Trial in Healthy Chinese Subjects.
08/29/2023	PubMed	Comparison of the Oral Calcimimetics Evocalcet and Cinacalcet in East Asian Patients on Hemodialysis with Secondary Hyperparathyroidism.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions